in ,

Vir, GSK plan to seek emergency use nod for COVID-19 antibody therapy (www.dailymail.co.uk)

GlaxoSmithKline’s Vir-7831 treatment has been so successful that scientists have stopped the study early. The UK-based firm is seeking emergency use authorisation in the US.

Real Life Ghosts Haunt And Possess Objects? | Mythbusters | Ft. William Shatner

How the pandemic could finally democratize commutes (bigthink.com)